We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
News and media menu
Published date
- November 2024 (1)
- September 2024 (1)
- August 2024 (1)
- July 2024 (1)
- May 2024 (1)
- March 2024 (1)
- February 2024 (1)
- January 2024 (1)
- December 2023 (3)
- November 2023 (2)
- September 2023 (2)
- August 2023 (2)
- July 2023 (1)
- June 2023 (1)
- March 2023 (2)
- December 2022 (3)
- November 2022 (1)
- July 2022 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- April 2021 (1)
- February 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (2)
- September 2020 (1)
- July 2020 (1)
- June 2020 (1)
- May 2020 (1)
- January 2020 (3)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- June 2019 (2)
- April 2019 (1)
- March 2019 (1)
- December 2018 (2)
- October 2018 (1)
- July 2018 (1)
- May 2018 (1)
- March 2018 (1)
- January 2018 (2)
- October 2017 (1)
- August 2017 (2)
- June 2017 (5)
- May 2017 (2)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- December 2016 (1)
- October 2016 (2)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
Search
78 result(s) found, displaying 26 to 50
- AACMC meeting 18, 11 March 2022The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #18.
- ODC Suspends Licences of Medicinal Cannabis Licence HolderOffice of Drug Control suspends cultivation and manufacture licences of Queensland Medicinal Cannabis Licence Holder Rapid Growth Pty Ltd.
- AACMC meeting 17, 24 June 2021The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #17.
- Enactment of the Narcotic Drugs Amendment (Medicinal Cannabis) Act 2021The Amendment Act provides for amendments to the Narcotic Drugs Act 1967 to support an innovative Australian medicinal cannabis industry for the benefit of Australian patients.
- AACMC meeting 16, 9 April 2021The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #16.
- AACMC meeting 15, 16 December 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #15
- Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021.
- Commission on Narcotic Drugs votes on recommendations for cannabis and cannabis related substancesOn 2 December 2020, Australia voted at the Commission on Narcotic Drugs (CND) on six recommendations concerning the scheduling of cannabis and cannabis related substances, made by the World Health Organisation (WHO) in January 2019 to the CND.
- Medicinal cannabis permit reform consultationThe ODC is seeking comments on a review of the structure, design and administrative processes relating to medicinal cannabis related permits.
- Commencement of fees and charges for cannabis-related manufactureCost recovery arrangements for cannabis-related manufacture licences and permits commenced on 1 November 2020.
- AACMC meeting 14, 23 September 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #14.
- Introduction of fees and charges for cannabis-related manufactureFrom 1 November 2020, subject to formal approval from the Federal Executive Council, cost recovery arrangements will be extended to cannabis-related manufacture licences and permits under the Medicinal Cannabis Scheme.
- AACMC meeting 13, 30 June 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #13.
- Reforms to Medicinal Cannabis Scheme Fees and ChargesChanges to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020.
- Australian Government proposes strengthening its stance against e-cigarettes containing vaporiser nicotineJoint media release - Department of Health (ODC) and Australian Border Force.
- AACMC meeting 12, 21 April 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #12.
- AACMC meeting 11, 19 November 2019The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #11.
- AACMC meeting 10, 12 June 2019The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #10.
- Single licence model consultation: Closing date for submissionsSubmissions in response to the Office of Drug Control's (ODCs) Consultation on Single Licence Model close COB Monday 3 February 2020.
- Implementation of the Review of the Narcotic Drugs Act 1967 (Cth)The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967.
- Tabling of Report on the Review into the 2016 medicinal cannabis amendments to the Narcotic Drugs Act 1967Report on the Review into the 2016 medicinal cannabis amendments to the Narcotic Drugs Act 1967 was tabled in Parliament on Thursday 5 September 2019.
- Boosting Australia's medicinal cannabis industryThe Australian Government will boost the nation's medicinal cannabis industry by prioritising projects that have been granted Major Project Status (MPS) and ultimately driving economic growth.
- AACMC meeting 9, 14 March 2019The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #9.
- AACMC meeting 8, 28 November 2018The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #8.
- Medicinal cannabis process clarification - from cultivation to manufactureA clarification of the processing rules around the timing of a medicinal cannabis licence and narcotics manufacturing licences.